Clinical Trials Logo

Filter by:
NCT ID: NCT04898335 Recruiting - Clinical trials for Mitral Regurgitation

Tendyne European Experience Registry

TENDER
Start date: April 15, 2021
Phase:
Study type: Observational [Patient Registry]

TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.

NCT ID: NCT04898296 Completed - Coronary Disease Clinical Trials

Exploration of Possible Reasons for the Discrepancy Between Expectation and Indication of Subjective Perceived Exertions

Ex-6-rate
Start date: July 1, 2021
Phase:
Study type: Observational

The 6-minute walk test is a test of physical performance in physiotherapy with lungs and heart patients (Pollentier 2010). However, only 8 and 11% of patients in everyday test situations report a score of 7 or higher on a scale of 0-10 for effort (Jehn 2009). This study is intended to explore, based on grounded theory, why the majority of patients do not assess themselves according to the almost maximum performance.

NCT ID: NCT04897048 Not yet recruiting - Clinical trials for Interstitial Lung Disease

Effect of Short-term Oxygen During CPET in ILD

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

In a randomized, sham-controlled crossover trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with interstitial lung disease.

NCT ID: NCT04896905 Completed - Covid19 Clinical Trials

Rehabilitation After Covid19-Clinical Results and Predictive Factors

Start date: October 1, 2020
Phase:
Study type: Observational [Patient Registry]

The aim of the study is to gain insight into the rehabilitation process and predictive factors for the outcome after rehabilitation in three patient groups: 1. SARS-CoV-2-positive patients in the isolation ward 2. Post-Covid-19 patients 3. Control group; matched for gender, age and co-morbidity

NCT ID: NCT04895462 Completed - Covid19 Clinical Trials

Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19

Start date: April 30, 2021
Phase:
Study type: Observational

Case-series and cohort studies have shown the feasibility of reperfusion therapies in patients with ischemic stroke and COVID-19, but due to the absence of a contemporary control group of non-COVID-19 patients, small sample size or lack of long-term outcome assessment, concerns regarding safety and efficacy of these treatments remain to be clarified. Taking into account its limitations, some studies documented higher rates of endovascular treatment complications such as clot fragmentation with distal embolization and vessel re-oclusion, to be more difficult to achieve recanalization after endovascular treatment, and higher rates of any intracerebral hemmorhage. The investigators aim is to assess in a large, multicenter and international cohort, the safety and outcomes of acute reperfusion therapies in patients with ischemic stroke and COVID-19, by comparison with a contemporary control group of patients with ischemic stroke and without COVID-19 from the same centers.

NCT ID: NCT04895202 Terminated - Clinical trials for Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study

SWISSMASIA
Start date: November 19, 2021
Phase:
Study type: Observational

This study is a national, prospective, multicenter, non-interventional (observational) study with the aim to describe the impact of Siponimod treatment in a real-world SPMS population in Switzerland who are treated with Siponimod as per Swiss label.

NCT ID: NCT04894578 Recruiting - Osteoarthritis Clinical Trials

A Comparative Trial of a Minimal-invasive Technique Versus Open Arthrodesis in the Treatment of Midfoot Arthritis

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

Group A: Patients suffering from midfoot arthritis after failed prior conservative therapy who undergo a reverse distal metatarsal minimal-invasive osteotomy Group B: Patients suffering from midfoot arthritis after failed prior conservative therapy who undergo a fusion of one or more midfoot (tarsometatarsal) joints

NCT ID: NCT04891523 Completed - Clinical trials for Microbial Colonization

Probiotic Modulation of Oral Microbiota

PROROBIOTICS
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Targeting human microbiota, in particular those of the gastrointestinal tract, by means of prebiotics, probiotics, symbiotics or antibiotics has gained interest for its potential in the management of human health. Oral bacterial communities have been extensively studied over the last decade both in normal and pathological states; however, little data are available on the possibility to modify microbiota composition in a controlled and 'non-aggressive' manner by using probiotics, in order to improve oral health. Saliva contains microorganisms attached to exfoliated human cells and released from oral biofilms; its microbiota is most similar (proportionally) to those of the dorsal and lateral tongue. In addition, bacteria belonging to genera Porphyromonas, Tannerella and Treponema, which contain species associated with periodontitis, are consistently identified in saliva. Salivary microbial communities are relatively stable and thus potentially interesting as an indicator of oral and general health. Indeed, it has been suggested that interventions aimed at improving oral health should target mucosal microbiota (to which saliva is most similar) in addition to dental microbial communities. Whole saliva also constitutes an alternative to gingival crevicular fluid when analysing analytes present in periodontal pockets. It has been suggested that saliva reflects a consensus inflammatory status of the whole mouth with potentially significant clinical relevance. Strain K12 of Streptococcus salivarius is available internationally as a food supplement, notably for oral hygiene. Several studies investigated the effectiveness of S. salivarius as a probiotic in the context of pharyngeal infections, halitosis, plaque formation and caries. Our study will focus on the effects of supplementation with this commercially available oral probiotic on the resident microbiota and inflammatory markers in order to identify signatures associated with resistance/susceptibility to colonization by probiotic strains.

NCT ID: NCT04890288 Not yet recruiting - Airway Management Clinical Trials

Apneic Intubation Critically Ill Children

Penguin
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study compares the actual standard of care of intubation in Swiss pediatric intensive care units vs the use of apneic oxygenation using either high flow or low flow oxygen to prevent hypoxemia and to prolong apnea time during intubation of critically ill children, with the final aim to improve airway management safety at PICUs. Primary study objective: To demonstrate that airway management supported by oxygen supplementation (either HFNC or low flow oxygen) can prevent significant desaturation (SpO2 > 85%) among patients in pediatric intensive care units (PICU) and neonatal intensive care units (NICU).

NCT ID: NCT04889872 Recruiting - Clinical trials for Aortic Valve Stenosis

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

PROGRESS
Start date: October 12, 2021
Phase: N/A
Study type: Interventional

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.